The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Ireland brings forward decision on whether to delay July 5 reopening

Sun, 27th Jun 2021 19:49

(Alliance News) - The Irish government is bringing forward a decision on whether to delay the next planned round of Covid-19 relaxations in Ireland, the Taoiseach has said.

Micheal Martin said Cabinet would now deliberate on the scheduled July 5 reopening of indoor hospitality in Ireland early this week.

A decision on the return to indoor dining and drinking had initially been expected later in the week, however, ministers have faced intensifying calls from bar and restaurant owners to urgently provide clarity.

They have made the point that they need to tell their staff whether or not they will be working on July 5.

Martin said there were a number of moving parts to the decision, including the spread of the Delta variant of Covid-19 in Ireland.

He said whether the green light will be given to administering hundreds of thousands of surplus AstraZeneca and Johnson & Johnson vaccines to younger age cohorts in Ireland would also be an "important factor".

In an interview with RTE, Martin said a "steady" approach to the reopening of society had worked to date and he wanted to make sure that there would be "no going back" to forced closures.

"It will be a decision that will be taken early in the week," said Martin.

Martin did not rule out the prospect of the reopening proceeding but with more robust infection control measures in place.

He said "various scenarios" could emerge in how hospitality could operate in the weeks ahead.

The AstraZeneca PLC and Johnson & Johnson's Janssen jabs are currently not given to younger adults in Ireland as a precautionary measure in response to rare incidences of blood clotting linked to the jabs.

Martin said the National Immunisation Advisory Committee was considering whether to alter that advice in the face of the Delta variant's emergence.

He said Niac's advice would influence the National Public Health Emergency Team's deliberations on whether to recommend delaying the July 5 relaxations.

"Given the fact that the Delta variant is here, it's an issue that merits re-examination, it is being re-examined, and Nphet is anxious that that examination would feed into its deliberations," he said.

Martin said the government would also need to examine modelling in respect of the potential impact of the Delta variant.

He said he would also look to how the variant has spread in other countries, such as the UK.

"The calculus is different now, the risk is different now than Christmas time for example," he said.

"We have 2.5 million people vaccinated now, fully vaccinated, with close to four million overall vaccine doses administered – between first and second doses [and] the older age cohorts have been protected.

"So all of that has to feed into the decisions that we take in respect to this.

"And I understand just how difficult and devastating a year it has been for hospitality in particular – we get that, we understand that, and we also understand the need to give early notice."

Martin added: "We're going to engage with public health authorities, cabinet colleagues, the other party leaders and make decisions that are sensible.

"We're very conscious in terms of the impact that the entire pandemic has had on the hospitality sector. I'm always conscious also from the other side of the coin that retail people would have said to me, 'look, when you open this time, we want to stay open' and the same applies to hospitality.

"The worst thing that can happen is you open somebody up and then you start closing again."

International travel for non-essential purposes is set to be permitted across the EU from July 19 as a consequence of the introduction of the bloc's Covid passport.

Martin indicated that Ireland would continue to keep aligned with the rest of Europe on that date.

"We're part of the European framework and we've given a commitment in relation to the 19th, so I think we will continue to operate the European Digital Certificate from the 19th onwards," he said.

Many people within the 60-69 age cohort in Ireland have faced extended waits for their second vaccine jabs.

Martin said action was being taken to address the situation, with the intention to have all second does administered by July 19.

Asked about the government timeline for reducing public spending on Covid-19 supports, Martin said Finance Minister Paschal Donohoe and Public Expenditure Minister Michael McGrath would be making a summer economic statement.

"There will be a clear overall fiscal framework adopted by government in respect of the deficit and over time bring that down," he added.

Martin said the shorter term continuation of current coronavirus policies was important, warning of the potential to "cut off the recovery as it's happening".

He said sectors of the economy would be "weaned off" subsidies "over time".

Meanwhile, the Department of Health confirmed 340 more positive cases of Covid-19 in Ireland on Sunday.

The latest figures also show there are 47 people in hospital with the virus, including 15 in intensive care.

By David Young, PA

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.